AI doctor in the ICU: can ChatGPT-5 save lives?
NCT ID NCT07293078
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an AI model (ChatGPT-5) can help doctors make better decisions for critically ill patients in the intensive care unit (ICU). About 1000 adults admitted to the ICU will be randomly assigned to standard care or care where the AI provides diagnostic and treatment suggestions. The goal is to see if the AI reduces medical errors and improves outcomes like survival and hospital stay length.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ChatGPT-5 (a large language model used for decision support)
What this could lead to
If successful, this could show that AI helps reduce medical errors in the ICU, potentially leading to safer care for critically ill patients.
What could go wrong
This is an early-phase trial (Phase 1/2) with 1000 patients, so results may not apply broadly. The AI's recommendations might not always be accurate or helpful, and there is a risk of over-reliance on technology.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Framingham Union Hospital/MetroWest Medical Center
Framingham, Massachusetts, 01702, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••